Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.

about

Functional oligopeptide as a novel strategy for drug delivery.Ocular bioanalysis: challenges and advancements in recent years for these rare matrices.

P2860

Q38740492-FA5A9F37-AFDF-448F-A1ED-8A78AC3872F5 Q47368829-E17FAC40-200D-400A-957D-05EB5C4C6270

P2860

Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.

Item

http://www.wikidata.org/entity/Q38934604

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Extended ocular drug delivery ...... rial options and applications.

@en

type

Item

label

Extended ocular drug delivery ...... rial options and applications.

@en

prefLabel

Extended ocular drug delivery ...... rial options and applications.

@en

P1476

Extended ocular drug delivery ...... rial options and applications.

@en

P2093

Emily Dosmar

http://www.w3.org/2001/XMLSchema#string

Jennifer J Kang-Mieler

http://www.w3.org/2001/XMLSchema#string

Wenqiang Liu

http://www.w3.org/2001/XMLSchema#string

William F Mieler

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering

Effect of drug type on the degradation rate of PLGA matrices

Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors

Protein compatibility of selected cross-linking reactions for hydrogels.

Ocular drug delivery.

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.

The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function.

Hydrogels in pharmaceutical formulations.

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

P304

611-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425247.2016.1227785

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27551742

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.

about

P2860

P2860

Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921